0 results for 'Endo Pharmaceuticals Inc'
Bulk of Delaware Lawsuit Targeting Opioid Makers, Distributors Clears Hurdle
A Delaware judge Monday blocked an attempt by a contingent of leading pharmaceutical manufacturers and distributors to escape a civil lawsuit by the state seeking to hold the companies liable for their alleged role in the state's opioid epidemic.
Opioid Defendants Lose Bid for Sanctions Over '60 Minutes' Episode
The proposed sanctions motion targeted plaintiffs lawyers who defendants claim made "misleading, inflammatory, and improper" statements on an episode last month.
Opioid MDL Judge Refuses to Dismiss Claims That Drug Companies Caused 'Man-Made Plague'
In the most substantial ruling to come out of the litigation over opioids, U.S. District Judge Dan Polster adopted most of a magistrate judge's Oct. 5 report and recommendation allowing RICO and public nuisance claims to go forward against opioid companies.
Opioid Judge Refuses to Dismiss Claims That Drug Companies Caused 'Man-Made Plague'
In the most substantial ruling to come out of the litigation over opioids, U.S. District Judge Dan Polster adopted most of a magistrate judge's Oct. 5 report and recommendation allowing RICO and public nuisance claims to go forward against opioid companies.
448 Tribes File 'Historic' Amicus Brief in Opioid Lawsuits
About 44 percent of pregnant women on the Blackfeet Tribe reservation in Montana tested positive for opioid use.
Opioid Makers Demand an 'Untenable Level of Specificity' in Dismissal Motions, Says Judge's Report
U.S. Magistrate Judge David Ruiz on Oct. 5 allowed most of the claims in a key case in a massive MDL against opioid companies to go forward, concluding that the complaint was far from a “fishing expedition.”
'Low Testosterone' Cases Come to an End Via Settlement
After kicking off with two verdicts awarding over $140 million, the docket of more than 6,000 cases alleging "low testosterone" treatments caused heart attacks and bloodclots comes to an end in a global settlement.
Abbott and AbbVie 'Low Testosterone' Cases Come to an End Via Settlement
After kicking off with two verdicts awarding over $140 million, the docket of more than 6,000 cases alleging "low testosterone" treatments caused heart attacks and bloodclots comes to an end in a global settlement.
Ohio AG Clears Hurdle With Key Decision in Opioid Litigation
A judge has allowed the state of Ohio's case to go forward against several opioid manufacturers in a ruling that plaintiffs lawyers are citing in…
Validation Under Section 205 of the Delaware General Corporation Law
In two recent opinions, The Cirillo Family Trust v. Moezinia, 2018 WL 3388398 (Del. Ch. July 11, 2018), and Charles Almond v. Glenhill Advisors, 2018 WL 3954733 (Del. Ch. Aug. 17, 2018), the Delaware Court of Chancery exercised its powers under Section 205 of the Delaware General Corporation Law (the DGCL) to validate acts that, due to technical problems in their authorization, may have otherwise been void or voidable.TRENDING STORIES
More from ALM
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
Resources
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now
A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster
Brought to you by HaystackID
Download Now
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now